The Fred Hutchinson Cancer Research Center in Seattle has
released new research
which explores whether taking cholesterol-lowering drugs may also
reduce the risk of dying from prostate cancer.
Commenting on the research Dr Iain Frame, Director of Research
at Prostate Cancer UK said: "Although several recent studies have
explored whether taking statins regularly can reduce the risk of
dying from prostate cancer, the results of this study still do not
provide enough evidence to support this. These results are based on
men already taking statins at the time their prostate cancer was
diagnosed and we would not advise that any man with the disease
start taking statins on the basis of this research. However we do
suggest that anyone with concerns about
the disease should discuss them with their GP."